Back to search
FDAFDA · Food and drugs·Recall number D-0543-2026

Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20

Published May 27, 2026 · Recall initiated: May 12, 2026

Summary

FDA records drug Class II recall D-0543-2026, published May 27, 2026 and initiated May 12, 2026. Recalling firm: ANI Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 3964 Cartons; Lot: Lot M251109, exp Nov 2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container; packets were found to be either empty or partially full.

What to do

Voluntary: Firm initiated · Letter

Get an email if ESTRADIOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ESTRADIOL
Manufacturer
ANI Pharmaceuticals, Inc.
Distributor
Nationwide in the USA
UPC
0370954531104
Lot
Lot M251109, exp Nov 2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20 recalled?

Yes. FDA published recall D-0543-2026 on May 27, 2026. Reported hazard: Defective Container; packets were found to be either empty or partially full.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ESTRADIOL. UPC: 0370954531104.